Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.

Anticancer research - 1 Jan 2000

Hernández Lourdes, Nuñez-Villarl María-José, Martínez-Arribas Fernando, Pollán Marina, Schneider José

Abstract excerpt

BACKGROUND: Breast cancer grows in a hormone-rich environment which influences its biological features and thus, ultimately, its clinical behavior. Circulating hormone levels were measured in premenopausal and postmenopausal breast cancer patients prior to surgery, and correlated with all available clinical and biological features of the tumors and with serum tumor marker levels. MATERIALS AND METHODS: FSH, LH,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoembryonic Antigen

Share to Luteinizing Hormone

Share to Mucin-1

Share to Premenopause

Share to Progesterone

Share to Prolactin

Source

Identifiers

PMID: 15816610

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.PMID 15816610Read ↗

Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.Semantic proximity Read ↗

Hormones and progeny of breast tumor cells.Semantic proximity Read ↗

Factors predictive of response to hormone therapy in breast cancer.Semantic proximity Read ↗

Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer.Semantic proximity Read ↗

Role of steroid hormones and growth factors in breast cancer.Semantic proximity Read ↗

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.Semantic proximity Read ↗

Connections between prolactin and ovarian cancerSemantic proximity Read ↗

Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.Semantic proximity Read ↗

Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.Semantic proximity Read ↗

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.Semantic proximity Read ↗

Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.Semantic proximity Read ↗

[Biomarkers in breast cancer with high over-expression of HER2 protein].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.